Clinical Trial Update: Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating isotretinoin in combination with interferon for recurrent cancers has completed, including cervical, esophageal, head and neck, lung,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Esophageal Cancer
• Head and Neck Cancer
• Lung Cancer
• Non-melanoma Skin Cancer
• Penile Cancer

Drugs mentioned

• ISOTRETINOIN (Isotretinoin)
• Interferon alfa-2b (interferon alfa-2b)

Snippet

Sponsor: Hoag Memorial Hospital Presbyterian | Conditions: Cervical Cancer, Esophageal Cancer | Phase 2 | Status: COMPLETED